140 studies found for:    "Biliary tract cancer"
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
Conditions: Biliary Tract Cancer;   Biliary Tract Neoplasms
Intervention: Drug: Nivolumab
2 Completed Second Line Therapy in Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: capecitabine and mitomycin;   Drug: Capecitabine
3 Completed
Has Results
A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma;   Biliary Tract Cancer;   Gallbladder Cancer
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Sorafenib
4 Withdrawn Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
Condition: Biliary Tract Cancer
Intervention: Drug: Irinotecan & Capecitabine
5 Recruiting Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer Who Failed Gemcitabine-based Combination Chemotherapy
Condition: Biliary Tract Cancer
Intervention: Drug: Lenvatinib
6 Recruiting A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer
Condition: Unresectable Biliary Tract Cancer
Intervention: Drug: Combination of nab-paclitaxel, gemcitabine and cisplatin
7 Terminated Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Conditions: Metastatic Biliary Tract Cancer;   Locally Advanced Biliary Tract Cancer
Interventions: Drug: Gemcitabine, Cisplatin;   Drug: S-1, Cisplatin
8 Completed Vessel Resection and Reconstruction of Biliary Tract Cancers
Condition: Biliary Tract Cancer
Intervention:
9 Completed Case Series Study of Biliary Tract Cancer Patients in Japan
Condition: Biliary Tract Cancer
Intervention:
10 Completed A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
Condition: Biliary Tract Cancer
Intervention:
11 Enrolling by invitation GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine/Cisplatin;   Drug: Gemcitabine/Cisplatin /S-1
12 Recruiting MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: MEK162+capecitabine
13 Completed Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: S-1
14 Recruiting Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers
Condition: Biliary Tract Cancer
Interventions: Drug: Abraxane (Nab-Paclitaxel);   Drug: Cisplatin;   Drug: Gemcitabine;   Behavioral: Phone Calls
15 Completed Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: S-1, Gemcitabine, Cisplatin
16 Recruiting Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine;   Drug: S-1
17 Unknown  Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer
Condition: Biliary Tract Cancer
Intervention: Drug: Docetaxel, Oxaliplatin
18 Completed
Has Results
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: gemcitabine;   Drug: cisplatin
19 Unknown  Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)
Condition: Biliary Tract Cancer
Intervention: Drug: S-1 oxaliplatin
20 Recruiting Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Gemcitabine , Cisplatin, Oral Rehydration Solution (ORS);   Drug: Gemcitabine , Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years